Erin Quirk
President presso TERNS PHARMACEUTICALS, INC.
Patrimonio netto: 492 000 $ in data 31/03/2024
Profilo
Erin Quirk is currently the President and Head of Research & Development at Terns Pharmaceuticals, Inc. Prior to this, Dr. Quirk worked at Gilead Sciences, Inc. as the Vice President of HIV Clinical Research from 2010 to 2018.
Dr. Quirk completed their undergraduate degree at Drew University and their graduate degree at The University of Colorado.
They also obtained a doctorate degree from The University of Colorado School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 23/01/2024 | 75 000 ( 0.12% ) | 492 000 $ | 31/03/2024 |
Posizioni attive di Erin Quirk
| Società | Posizione | Inizio |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | President | 07/02/2024 |
Precedenti posizioni note di Erin Quirk
| Società | Posizione | Fine |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/09/2018 |
Formazione di Erin Quirk
| Drew University | Undergraduate Degree |
| The University of Colorado School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| TERNS PHARMACEUTICALS, INC. | Health Technology |
- Borsa valori
- Insiders
- Erin Quirk
